157 related articles for article (PubMed ID: 19789512)
1. Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD.
Skyba P; Kluchova Z; Joppa P; Petrasova D; Tkacova R
Med Sci Monit; 2009 Oct; 15(10):CR528-533. PubMed ID: 19789512
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
[TBL] [Abstract][Full Text] [Related]
3. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
4. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
5. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
6. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
7. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
[TBL] [Abstract][Full Text] [Related]
8. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?
Breyer MK; Spruit MA; Celis AP; Rutten EP; Janssen PP; Wouters EF;
Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024
[TBL] [Abstract][Full Text] [Related]
9. Correlation of oxidative status with BMI and lung function in COPD.
Vibhuti A; Arif E; Deepak D; Singh B; Qadar Pasha MA
Clin Biochem; 2007 Sep; 40(13-14):958-63. PubMed ID: 17631288
[TBL] [Abstract][Full Text] [Related]
10. Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases.
Budweiser S; Meyer K; Jörres RA; Heinemann F; Wild PJ; Pfeifer M
Eur J Clin Nutr; 2008 Mar; 62(3):436-43. PubMed ID: 17342162
[TBL] [Abstract][Full Text] [Related]
11. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
12. Determinants of BMI in patients with COPD.
Karadag F; Karul AB; Cildag O; Altun C; Gurgey O
Respirology; 2004 Mar; 9(1):70-5. PubMed ID: 14982605
[TBL] [Abstract][Full Text] [Related]
13. Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation.
Budweiser S; Heinemann F; Meyer K; Wild PJ; Pfeifer M
Respir Care; 2006 Feb; 51(2):126-32. PubMed ID: 16441956
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
15. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
16. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.
Baldi S; Ruffini E; Harari S; Roviaro GC; Nosotti M; Bellaviti N; Venuta F; Diso D; Rea F; Schiraldi C; Durigato A; Pavanello M; Carretta A; Zannini P
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1616-22. PubMed ID: 16308007
[TBL] [Abstract][Full Text] [Related]
17. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
18. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
[TBL] [Abstract][Full Text] [Related]
19. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
20. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
